Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. (2015)
Attributed to:
Gene Therapy for Tay-Sachs and Sandhoff diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)61841-9
PubMed Identifier: 25819691
Publication URI: http://europepmc.org/abstract/MED/25819691
Type: Journal Article/Review
Volume: 385
Parent Publication: Lancet (London, England)
Issue: 9985
ISSN: 0140-6736